DOI : 10.1055/s-00000054

Pharmacopsychiatry

Issue 05 · Volume 38 · September 2005 DOI: 10.1055/s-002-4370

24th Symposium of the AGNP

Munich, 5–8 10 2005
Dr. Sieglinde Modell – Prof. Dr. Rainer Rupprecht


A001
Adamovic, I.; Grohmann, R.; Kropp, S.; Rüther, E.; Degner, D.: Drug safety monitoring in psychiatry: drug induced seizures in antidepressant treatment
A002
Adli, M.; Wiethoff, K.; Baghai, T. C.; Stamm, T.; Schloth, D. L.; Smolka, M.; Bottlender, R.; Fisher, R.; Cordes, J.; Kirchheiner, J.; Möller, H. J.; Bauer, M.: Evaluating algorithm-guided treatment for depression: The German Algorithm Project (GAP)
A008
Bartels, M.; Plewnia, C.: Aripiprazole in Tourette syndom
A010
Beckers, M.; Köhnlein, O. C.; Lutz, R.; Schmauss, M.; Messer, T.: Investigation of plasma level concentrations of mirtazapine regarding compliance and comedication
A011
Beer, F.; Heinrich, H.; Springer, S.; Rüth, U.; Freisleder, F. J.: Quetiapine in the treatment of psychotic adolescents
A013
Beitinger, P. A.; Dalal, M. A.; Wehrle, R.; Fulda, S.; Schuld, A.; Wetter, T. C.; Pollmächer, T.: Impaired glucose tolerance in patients with narcolepsy
A014
Bermpohl, F.; Fregni, F.; Boggio, P. S.; Thut, G.; Northoff, G.; Rigonatti, S. P.; Marcolin, M. A.; Pascual-Leone, A.: Repetitive TMS and major depression: Acute response varies with stimulation site and depression severity
A015
Bertram, I.; Bernstein, H. G.; Lendeckel, U.; Keilhoff, G.; Bukowska, A.; Dobrowolny, H.; Stauch, R.; Falkai, P.: Strongly reduced number of neuregulin–1- alpha expressing prefrontal gray and white matter neurons in schizophrenia
A018
A019
Brakemeier, E. L.; Bajbouj, M.; Danker-Hopfe, H.; Luborzewski, A.: Efficacy of levetiracetam in the treatment of restless legs syndrome (Keppra-RLS-Study)
A021
Braun, I.; Genius, J. J. K.; Kastrup, N.; Hartmann, A. M.; Giegling, I.; Möller, H. J.; Rujescu, D.: Ultrastructural alterations of GABAergic interneurons in an animal model of psychosis
A023
Breu, J.; Deussing, J. M.; Wurst, W.: CRHR-1 signalling inhibits AMPA-receptor internalisation
A024
Brisch, R.; Bernstein, H. G.; Krell, D.; Stauch, R.; Trübner, K.; Dobrowolny, H.; Gos, T.; Bielau, H.; Bogerts, B.: A decreased cell density in the lateral septal nucleus in bipolar patients and the reversed effects of lithium treatment
A028
Bschor, T.; Ritter, D.; Lewitzka, U.; Bauer, M.; Adli, M.; Baethge, C.; Uhr, M.; Ising, M.: Effects of lithium on the HPA axis in patients with unipolar major depression
A029
Clement, H. W.; Fleischhaker, C.; Schulz, E.: Therapeutic drug monitoring of SSRI's in adolescents
A031
Cohrs, S.; Meier, A.; Neumann, A. C.; Jordan, W.; Rüther, E.; Rodenbeck, A.: The atypical antipsychotic ziprasidone demonstrates polysomnographic features of an antidepressant
A032
Colla, M.; Schubert, F.; Heidenreich, J.; Seifert, F.; Bubner, M.; Bajbouj, M.; Heuser, I.: 3T-Spectroscopy in the hippocampus and cognitive status of lithium-treated euthymic bipolar patients
A036
Czibere, L.; Keßler, M. S.; Birg, I.; Panhuysen, M.; Pütz, B.; Deussing, J. M.; Turck, C. W.; Landgraf, R.: Glyoxalase I: Implications for an enzyme involved in trait anxiety
A038
Deussing, J. M.; Kühne, C.; Panhuysen, M.; Pütz, B.; Breu, J.; Paez-Pereda, M.; Holsboer, F.; Wurst, W.: Gene expression profiling reveals corticotropin-releasing hormone (CRH) dependent signaling pathways
A041
Dittmann, R. W.; Hagenah, U.; Junghanß, J.; Mästele, A.; Mehler-Wex, C.; Meyer, E.; Schmidt, M. H.; Remschmidt, H.; Schlamp, D.; Schulte-Markwort, M.; Schulz, E.; Poustka, F.: Olanzapine in adolescent and young adult patients with schizophrenia: findings in male and female patients
A043
Douhet, A.; Riedel, M.; Spellmann, I.; Dehning, S.; Cerovecki, A.; Zill, P.; Müller, N.; Möller, H. J.; Bondy, B.: Genetic polymorphisms of the beta2-adrenoceptor gene might influence metabolic disturbances during antipsychotic treatment
A045
Drieling, T.; Biedermann, N. C.; Schärer, L. O.; Langosch, J. M.: Psychotropic drug-induced change of weight: a review
A047
A048
Eckert, A.; Scherping, I.; Bonert, A.; Hauptmann, S.; Müller-Spahn, F.; Müller, W. E.: Mitochondrial failure precedes amyloid beta plaques deposition in APP transgenic mice
A049
Eckert, G. P.; Franke, C.; Jourdan, C.; Johnson-Anuna, L.; Wood, W. G.; Müller, W. E.: Simvastatin elevates anti-apoptotic Bcl–2 levels in guinea pig brain
A051
Engelien, A.; Kugel, H.; Konrad, C.; Schöning, S.; Schäfer, S.; Pletziger, E.; Beizai, P.; Kersting, A.; Ohrmann, P.; Lehmann, W.; Heindel, W. L.; Arolt, V.: Hormonal influences on cerebral networks for cognition demonstrated with fMRI at 3 T
A053
Erdag, S.; Wilms, S.; Bozkurt, B.; Vogel, T.; Kell, S.; Däubener, W.; Hinze-Selch, D.: Toxoplasmosis in psychiatric disorders: immunologic and epidemiologic findings
A054
Erhardt, A.; Seaman, S. R.; Lucae, S.; Kern, N.; Unschuld, P. G.; Welt, T.; Ising, M.; Salyakina, D.; Pütz, B.; Lieb, R.; Binder, E. B.; Müller-Myhsok, B.; Holsboer, F.; Keck, M. E.: Genetic implications of the endocannabinoid system in anxiety disorders versus depressive disorders: is there any evidence for the continuum hypothesis?
A055
Erhardt, A.; Unschuld, P. G.; Kern, N.; Welt, T.; Ising, M.; Keck, M. E.: Responsiveness of the hypothalamic-pituitary-adrenocortical system in patients with agoraphobia and panic attacks
A058
Feutl, S.; Zhang, Y.; Schmorl, P.; Hauser, U.; Schramm, J.; Emrich, H. M.; Dietrich, D. E.: Amantadin reduces activation of the cingulate gyrus in patients with obsessive-compulsive disorder: a LORETA based study
A060
Flügge, G.; Abumaria, N.; Rygula, R.; Havemann-Reinecke, U.; Rüther, E.; Fuchs, E.: Gene regulation in the dorsal raphe nucleus during chronic social stress and citalopram treatment
A061
Friess, E.; Ambrosius, U.; Lietzenmayer, S.; Wichniak, A.; Winkelmann, J.; Yassouridis, A.; Holsboer, F.: Sleep architecture and sleep continuity in healthy twins
A062
Frodl, T. S.; Zetzsche, T.; Schmitt, G.; Schlossbauer, T.; Jäger, M. W.; Bottlender, R.; Reiser, M.; Möller, H. J.; Meisenzahl, E.: Hippocampal and amygdala volume changes in patients with major depression and healthy controls during a three year follow-up
A065
Genius, J. J. K.; Benninghoff, J.; Hartmann, A. M.; Giegling, I.; Möller, H. J.; Rujescu, D.: Neuronal proliferation in an animal model of psychosis. Implications for the pathomechanism underlying schizophrenia
A066
Giacomuzzi, S.; Ertl, M.; Pavlic, M.; Libiseller, K.; Riemer, Y.; Kemmler, G.; Rössler, H.; Grubwieser, P.; Rabl, W.; Hinterhuber, H.: Outpatient drug treatment centre and patterns of drug use
A067
Giacomuzzi, S.; Pavlic, M.; Ertl, M.; Ebmer, S.; Riemer, Y.; Hinterhuber, H.: Buprenorphine mainentenance treatment: Effects of dose on the patients psychical and physical condition
A068
Giegling, I.; Goldman, D.; Zhou, Z.; Dietrich, I.; Hartmann, A. M.; Möller, H. J.; Rujescu, D.: Association of suicidal behavior with the TPH2 gene
A069
Giesler, M.; Thum, A.; Haag, A.; Wartenberg-Demandt, A.; McGregor, G.; Krieg, J. C.; Kundermann, B.; Hemmeter, U. M.: Effects of Neurapas® balance on sleep EEG, cognitive performance and mood: A double-blind randomised cross-over study in healthy volunteers
A071
Göder, R.; Hinze-Selch, D.; Huchzermeier, C.; Koch, J. M.; Seeck-Hirschner, M.; Fritzer, G.; Aldenhoff, J. B.: Sleep and outcome in depressed patients treated with interpersonal psychotherapy
A072
Gouzoulis-Mayfrank, E.; Heekeren, K.; Neukirch, A.; Daumann, J.: Orienting of attention in the 5HT2A agonist and NMDA antagonist model of psychosis
A074
Grözinger, M.; Paulzen, M.; Nickl-Jockschat, T.: Drug interference can completely extinguish quetiapine blood levels
A077
Gruber, O.; Scherk, H.; Kamer, T.; Kemmer, C.; Reith, W.; Falkai, P.: A voxel-based morphometric study of gray matter density changes in euthymic patients with bipolar I disorder
A080
Hajak, G.; Langguth, B.; Sand, P.; Landgrebe, M.; Eichhammer, P.: Low frequency rTMS: Induction of neuroplastic effects
A081
Hanstein, R.; Bayatti, N.; Behl, C.; Clement, A.: Corticotropin releasing hormone (CRH) is a neuroprotective peptide
A082
Hartmann, A. M.; Genius, J. J. K.; Filep, L.; Räder, H.; Giegling, I.; Möller, H. J.; Rujescu, D.: Identification of schizophrenia genes in an animal model for psychosis
A083
Hatzinger, M.; Brand, S.; von Wyl, A.; Perren, S.; von Klitzing, K.; Holsboer-Trachsler, E.: Stress and sleep in Kindergarten children: Predictors of psychiatric morbidity?
A084
Havemann-Reinecke, U.; Bachus, E.; Riegel, A.; Stoppe, G.: White matter lesions and alcohol dependence
A085
Havemann-Reinecke, U.; Rygula, R.; Abumaria, N.; Rüther, E.; Hiemke, C.; Flügge, G.: Citalopram abolishes depressive-like symptoms evoked by chronic social stress in rats
A087
Hemmeter, U. M.; Nekwasil, B.; Thum, A.; Schneyer, T.; Bender, M.; Giesler, M.; Krieg, J. C.: Serotonergic stimulation in relation to approach-avoidance behavior in patients with anxiety disorders and borderline personality disorder
A090
A092
A093
Himmerich, H.; Fulda, S.; Schaaf, L.; Beitinger, P. A.; Schuld, A.; Pollmächer, T.: Does antidepressant therapy improve glucose metabolism?
A094
Himmerich, H.; Binder, E. B.; Künzel, H. E.; Schuld, A.; Lucae, S.; Uhr, M.; Pollmächer, T.; Holsboer, F.; Ising, M.: Successful antidepressant therapy restores the disturbed interplay between TNF-alpha system and HPA axis
A095
Himmerich, H.; Fulda, S.; Künzel, H. E.; Pfennig, A.; Dzaja, A.; Cummings, D. E.; Pollmächer, T.: Ghrelin plasma levels during psychopharmacological treatment
A097
Hornung, O. P.; Regen, F.; Warnstedt, C.; Danker-Hopfe, H.; Lammers, C. H.: Sleep-related memory consolidation in patients with borderline personality disorder
A099
Hübner-Liebermann, B.; Spießl, H.; Cording, C.: Psychopharmacological pre-treatment of inpatients with schizophrenia
A101
Hüll, M.; Haake, E.; Slawik, H.; Fiebich, B. L.: Modulation of microglial prostaglandin production by norepinephrine
A102
A103
Huth, V.; Knolle-Veentjer, S.; Ferstl, R.; Hinze-Selch, D.: Schizophrenia-weight gain-atypicals: a paradigm for delay of nutritional gratification
A104
Ising, M.; Binder, E. B.; Dose, T.; Horstmann, S.; Kern, N.; Kloiber, S.; Künzel, H. E.; Lucae, S.; Pfennig, A.; Unschuld, P. G.; Modell, S.; Holsboer, F.: Change in HPA system function predicts treatment response in depression
A108
Jordan, W.; Cohrs, S.; Degner, D.; Meier, A.; Rodenbeck, A.; Mayer, G.; Pilz, J.; Rüther, E.; Kornhuber, J.; Bleich, S.: Evaluation of oxidative stress measurements in obstructive sleep apnea syndrome
A109
Juckel, G.; Schlagenhauf, F.; Koslowski, M.; Filonow, D.; Knutson, B.; Wrase, J.; Heinz, A.: Ventral striatum activation by typical versus atypical neuroleptics in a fMRI paradigm with monetary incentive stimuli
A111
Kasper, S.; Winkler-Pjrek, E.: Strategies for psychopharmacology during pregnancy
A112
Kastrup, N.; Genius, J. J. K.; Braun, I.; Hartmann, A. M.; Giegling, I.; Möller, H. J.; Rujescu, D.: Neurotrophic support and apoptosis in an animal model of psychosis based on chronic NMDA-antagonism
A113
Keil, U.; Scherping, I.; Hauptmann, S.; Eckert, A.; Müller, W. E.: Stabilization of mitochondrial function by piracetam
A117
Kirmeier, T.; Turck, C. W.; Holsboer, F.; Rein, T.: Proteomic search for intracellular binding sites of antidepressants
A118
Kirschbaum, K. M.; Müller, M. J.; Mobascher, A.; Malevani, J.; Hiemke, C.: Therapeutic drug monitoring of aripiprazole
A120
Kluge, M.; Schüssler, P.; Dresler, M.; Steiger, A.: Sleep-onset REM sleep in obsessive compulsive disorder
A121
Koch, J. M.; Kuhlmann, C.; Stengel, M.; Aldenhoff, J. B.: Cell-type specific coupling of the 5-HT1a-receptor
A122
Koch, J. M.; Hinze-Selch, D.; Huchzermeier, C.; Schulz-Du Bois, A. C.; Aldenhoff, J. B.: The association of CREB-phosphorylation and treatment-response in depression: Findings in pharmacological and non-pharmacological treatment
A123
Koch, K.; Wagner, G.; von Consbruch, K.; Nenadic, I.; Schultz, C. C.; Ehle, C.; Reichenbach, J. R.; Sauer, H.; Schlösser, R.: Differential temporal dynamics of cognitive learning processes in patients with schizophrenia: An event-related fMRI study
A126
Köhnlein, O. C.; Beckers, M.; Schwander, S.; Lutz, R.; Schmauss, M.; Messer, T.: Therapeutic drug monitoring of quetiapine regarding plasma level concentration and dependence from daily dosage
A128
Kraft, S.; Scherk, H.; Kemmer, C.; Schneider-Axmann, T.; Falkai, P.; Gruber, O.: Neuropsychology of obsessive-compulsive disorder compared to bipolar affective disorder and a healthy control group
A130
Kraus, T.; Schanze, A.; Bayerlein, K.; Hillemacher, T.; Reulbach, U.; Gröschl, M.; Kornhuber, J.; Bleich, S.: Ghrelin levels are increased in alcoholism
A131
Kumsta, R.; Entringer, S.; Koper, J. W.; Hellhammer, D.; Wüst, S.: GR gene haplotypes and hypothalamus-pituitary-adrenal (HPA) axis responses to stress
A132
Kungel, M.; Ebrecht, M.; Modell, S.; Werner, C.; Spevakné-Göröcs, T.: Effects of long-term (up to 5 years) open-label treatment with aripiprazole
A136
Langguth, B.; Eichhammer, P.; Sand, P.; Hajak, G.: Quetiapine induced modulation of cortical excitability
A137
Langguth, B.; Landgrebe, M.; Sand, P.; Hajak, G.; Eichhammer, P.: rTMS for the treatment of auditory phantom perceptions
A138
Langguth, B.; Perna, M.; Eichhammer, P.; Sand, P.; Hajak, G.: Affect and colour perception – a neurophysiological approach
A139
Langguth, B.; Landgrebe, M.; Sand, P.; Hajak, G.; Eichhammer, P.: Modulation of cerebellothalamocortical pathways by cerebellar rTMS
A140
Lang-Rollin, I. C.; Wochnik, G. M.; Holsboer, F.; Rein, T.: Effects of TPR proteins on steroid receptor signaling
A143
Leweke, F. M.; Giuffrida, A.; Koethe, D.; Nolden, B. M.; Gerth, C. W.; Schreiber, D.; Gross, S.; Juelicher, A.; Klosterkötter, J.; Piomelli, D.: The role of the endogenous cannabinoid system in schizophrenia
A144
Lewitzka, U.; Müller-Oerlinghausen, B.; Felber, W.; Brunner, J.; Lauterbach, E.; Hawellek, B.; Rujescu, D.; Bondy, B.; Rao, M. L.; Maier, W.; Ising, M.; Bronisch, T.: MAO-B acitivity in platelets associated with suicide attempts in depressed patients
A145
Lieb, K.; Jacob, G.; Rüsch, N.; Tebartz van Elst, L.: Disturbed fronto-limbic brain circuits in borderline personality disorder
A146
Lieb, M.; Kagerer, S.; Hock, B.; Lehnert, P.; Limmer, C.; Soyka, M.: Cognitive function during substitution treatment
A148
Lu, A.; Steiner, M.; Engelholm, M.; Wotjak, C. T.; Holsboer, F.; Wurst, W.; Deussing, J. M.: Site-specific overexpression of corticotropin-releasing hormone (CRH) in the mouse brain – modelling central CRH system hyperactivity
A149
Luborzewski, A.; Schubert, F.; Brakemeier, E. L.; Gallinat, J.; Pütz, C.; Seifert, F.; Bajbouj, M.: Abnormal cingular neurochemistry in patients with major depression: Evidence from 3 tesla proton magnetic resonance spectroscopy (1H-MRS)
A150
A151
A153
Maler, J. M.; Esselmann, H.; Dyrks, T.; Klafki, H.; Fiszer, M.; Paul, S.; Reulbach, U.; Lewczuk, P.; Rüther, E.; Kornhuber, J.; Wiltfang, J.: Specific inhibition of β-amyloid peptide secretion by ZK808762 mimicks the effect of non-steroidal anti-inflammatory drugs
A154
Maler, J. M.; Spitzer, P.; Herrmann, M.; Esselmann, H.; Lewczuk, P.; Kornhuber, J.; Wiltfang, J.: β-Amyloid secretion by human monocytes
A158
Meier, A.; Neumann, A. C.; Jordan, W.; Hüther, G.; Rodenbeck, A.; Rüther, E.; Cohrs, S.: Reduced cortisol excretion in healthy subjects under treatment with ziprasidone
A159
Messer, T.; Fessel-Denk, U.; Straach, P.; Schmauss, M.: Differences in the prescription of antipsychotics in Germany
A160
Modell, S.; Werner, C.; Spevakné-Göröcs, T.; Kungel, M.; Ebrecht, M.: Efficacy and safety of lower doses of aripiprazole
A162
Möller, O.; Nguyen, D. H.; Dannlowski, U.; Deckert, J.; Arolt, V.; Hetzel, G.: Ziprasidone in the treatment of major depressive disorder with psychotic features
A163
Mueller, E.; Stöhr, K.; Weixler, C.; Kuenzel, H. E.; Schuld, A.; Pollmächer, T.: Efficacy of electroconvulsive therapy for depressive disorders in a Bavarian district hospital
A166
Müller-Preuss, P.; Wiesner, E.; Lu, A.; Deussing, J. M.; Kimura, M.: CNS-specific overexpression of CRH alters sleep-wake behavior in transgenic mice
A167
Müller-Vahl, K. R.; Berding, G.; Schneider, U.; Emrich, H. M.: Treatment of Tourette-syndrome with cannabinoids: results from clinical and neuroimaging studies
A168
Murck, H.; Manku, M.; Gringras, M.; Beaumont, G.: Ethyl-Eicosapentaenoate for depression with melancholic features
A169
Murck, H.; Spitznagel, H.; Ploch, M.; Schmidt, U.: Hypericum extract LI160 for depression with atypical features
A173
Neuhaus, A.; Staedtgen, M.; Bajbouj, M.; Kalus, P.; von Haebler, D.; Gallinat, J.: Effects of smoking history on cortical activation patterns during target detection
A174
Nothdurfter, C.; Eser, D.; Schüle, C.; Zwanzger, P. M.; Marcuse, A.; Noack, I.; Möller, H. J.; Rupprecht, R.; Baghai, T. C.: The influence of concomitant neuroleptic medication on safety, tolerability and clinical effectiveness of electroconvulsive therapy
A175
Nyhuis, P. W.; Gastpar, M.: Opiate treatment in ECT-resistant depression
A176
A177
Opgen-Rhein, C.; Neuhaus, A.; Urbanek, C.; Wieseke, N.; Hahn, E.; Strathmann, S.; Dettling, M.: The ANT as a potential neurocognitive endophenotype of schizophrenia
A178
Otte, C.; Hart, S.; Neylan, T.; Marmar, C.; Yaffe, K.; Mohr, D.: A meta-analysis of cortisol response to challenge in human aging: importance of gender
A179
Pajonk, F. G.; Schmitz, F. S.; Birkenheier, C.; Classen, W.; Caspari, D.; Höffler, J.; Hofmann, W.; Kaiser, M.; Rambach, S.; Ross, B.; Falkai, P.: Psychopharmacological treatment of schizophrenia–How is medication favoured by the patient? First results of the FAME I–Study
A182
Pogarell, O.; Juckel, G.; Norra, C.; Mulert, C.; Folkerts, M.; Mergl, R.; Frodl, T. S.; Möller, H. J.; Hegerl, U.: Auditory cortical stimulus processing in major depression: effects of noradrenergic versus serotonergic agents
A184
Preuss, U. W.; Zill, P.; Koller, G.; Bondy, B.; Soyka, M.: Genetic variants of monoaminergic transporters in alcohol withdrawal
A185
Quednow, B. B.; Frommann, I.; Falkai, P.; Maier, W.; Wagner, M.: Sensorimotor gating and habituation of the startle response in the prodrome of schizophrenia
A187
Reisinger, B.; Mueller, E.; Kropp-Hartmann, B.; Wölflick, D.; Zimmerer, C.; Schuld, A.; Pollmächer, T.: Metabolic abnormalities in patients with chronic psychiatric disorders receiving long-term psychopharmacological treatment
A188
Rentzsch, J.; Penzhorn, A.; Wolf, T.; Jockers-Scherübl, M. C.: Preattentive information processing in schizophrenia with cannabis abuse: an ERP study
A189
Reppermund, S.; Horstmann, S.; Lucae, S.; Kloiber, S.; Dose, T.; Holsboer, F.; Ising, M.: Stress coping and personality traits in acute depression and after improvement
A196
Rodenbeck, A.; Ruppert, N.; Bethge, A.; Hüther, G.; Meier, A.; Jordan, W.; Cohrs, S.: Elevated evening cortisol secretion due to underlying psychiatric disorders independent of the sleep-related disease
A197
Rosenhagen, M. C.; Schüssler, P.; Schmidt, U.; Yassouridis, A.; Steiger, A.: Sleep-EEG effects of high-dose corticosteroid treatment in multiple sclerosis
A198
Rosenhagen, M. C.; Uhr, M.; Schüssler, P.; Steiger, A.: Elevated plasma ghrelin levels in night eating syndrome
A199
Rothermundt, M.; Falkai, P.; Ponath, G.; Abel, S.; Diedrich, M.; Hetzel, G.; Peters, M.; Siegmund, A.; Maier, W.; Schramm, J.; Suslow, T.; Ohrmann, P.; Arolt, V.: Glial cell dysfunction in schizophrenia indicated by increased S100B in the CSF
A200
Rummel, C.; Hansen, W. P.; Kissling, W.: „Patients consult patients“: first results
A201
Rummel, C.; Peters, S.; Kissling, W.: Compliance in schizophrenic patients: A cross-sectional study
A203
Salyakina, D.; Binder, E. B.; Ising, M.; Uhr, M.; Lucae, S.; Müller-Myhsok, B.: Within- and Inter- gene interactions in FKBP5 and GR genes and its association with early response
A204
Sartorius, A.; Hermann, D.; Welzel, H.; Walter, S.; Skopp, G.; Diehl, A.; Ende, G.; Mann, Ka: Dorsolateral prefrontal cortex and basal ganglia alterations in cannabis consumers using proton MR spectroscopy
A205
Savaskan, E.; Eckert, A.; Ravid, R.; Jockers, R.; Müller-Spahn, F.: Fas-associated phosphatase–1 (FAP–1) in Alzheimer’s disease hippocampus
A207
Schanze, A.; Kornhuber, J.; Kraus, T.; Reulbach, U.; Gröschl, M.; Scheuchenzuber, M.: Ghrelin – a modulator of depression associated eating disturbances
A208
Schindler, F.; Petersen, K.; Anghelescu, I. G.; Thomasius, R.: The prevalence of antisocial personality disorder in ecstasy abusers
A209
A210
Schloth, D. L.; Kirchheiner, J.; Nickchen, K.; Stamm, T.; Wiethoff, K.; Tsahuridu, M.; Bauer, M.; Adli, M.: Lithium augmentation in treatment-resistant depression: influence of polymorphisms in tryptophan hydroxylase 2 gene (TPH2) on therapy response
A213
Schönknecht, P.; Hunt, A.; Kaiser, E.; Toro, P.; Thomann, P.; Schröder, J.: Total and phospho-tau (threonin 181) in geriatric major depression and mild cognitive impairment
A215
Schüle, C.; Baghai, T. C.; Eser, D.; Schaaf, L.; Rupprecht, R.: The combined T3/TRH-test in depressed patients and healthy controls
A217
Schüssler, P.; Weikel, J.; Kluge, M.; Dresler, M.; Uhr, M.; Yassouridis, A.; Steiger, A.: The sleep modulating effects of peptides after sleep deprivation
A218
Schüssler, P.; Uhr, M.; Ising, M.; Weikel, J.; Schmid, D. A.; Matthias, S.; Held, K.; Steiger, A.: Effects of sleep deprivation on ghrelin, ACTH, GH and cortisol secretion in normal controls
A219
Schüssler, P.; Kluge, M.; Dresler, M.; Yassouridis, A.; Held, K.; Zihl, J.; Steiger, A.: Effects of progesterone on sleep and cognition in healthy postmenopausal women
A220
Siegmund, A.; Dahlhoff, M.; Wotjak, C. T.: Maternal factors in a mouse model of posttraumatic stress disorder
A222
Spellmann, I.; Riedel, M.; Müller, N.; Strassnig, M.; Douhet, A.; Dehning, S.; Möller, H. J.: Cognitive benefits of quetiapine versus risperidone in schizophrenia
A223
Spevakné-Göröcs, T.; Kungel, M.; Ebrecht, M.; Modell, S.; Werner, C.: Aripiprazole reduces agitation without excessive sedation
A224
Steiger, A.; Kuenzel, H. E.; Uhr, M.; Ackl, N.; Hatzinger, M.; Held, K.; Holsboer-Trachsler, E.; Ising, M.; Kaschka, W.; Kasper, S.; Konstantinidis, A.; Sonntag, A.: Trimipramine is equivalent to combined treatment with amitriptyline and haloperidol in patients with delusional depression
A225
Sterlemann, V.; Schmidt, M.; Alam, S.; Ganea, K.; Greetfeld, M.; Holsboer, F.; Müller, M. B.: A new model of chronic social stress in mice: long-term neuroendocrine and behavioural consequences
A227
Stoppe, G.; Bergmann, F.; Roth-Sackenheim, C.; von der Damerau-Dambrowski, V.; Bohlken, J.; Wächtler, C.: Outpatient care of dementia: an algorhythm for the cooperation of family physicians and specialists in Germany
A229
A230
Thalmeier, A.; Giegling, I.; Dietrich, I.; Schneider, B.; Maurer, K.; Hartmann, A. M.; Möller, H. J.; Strimmer, K.; Schaefer, J.; Bratzke, H.; Schnabel, A.: Identification of differentially expressed genes in the brains of suicide victims; a microarray analysis study
A232
Thoeringer, C. K.; Binder, E. B.; Lucae, S.; Erhardt, A.; Unschuld, P. G.; Harbich, D.; Roedel, A.; Uhr, M.; Ohl, F.; Lieb, R.; Müller-Myhsok, B.; Müller, M. B.; Holsboer, F.: GABA transporter1 (GAT1) inhibition mediates distinct emotional and cognitive processes and represents a possible treatment strategy compensating genetic polymorphisms in panic disorder
A233
Thum, A.; Rocamora, R.; Giesler, M.; Haag, A.; Becker, A.; Penzel, T.; Krieg, J. C.: REM-Sleep in patients with dementia of Alzheimer and frontotemporal type under long term treatment with cholinesterase inhibitors
A234
Touma, C.; Bunck, M.; Keßler, M. S.; Nußbaumer, M.; Landgraf, R.: Mice selected for high or low stress reactivity: a proposed model for affective disorders
A235
Treiber, K.; Henke, B.; Müller, W. E.: Hyperforin activates TRP channels via tyrosine kinases
A236
Tsolakidou, A. E.; Panhuysen, M.; Pütz, B.; Sillaber, I.; Trümbach, D.; Holsboer, F.: Stress-regulated genes in the brain of two mouse strains with differential responsiveness to antidepressants
A237
Unschuld, P. G.; Ising, M.; Erhardt, A.; Lucae, S.; Welt, T.; Kloiber, S.; Kern, N.; Salyakina, D.; Binder, E. B.; Brückl, T.; Uhr, M.; Müller-Myhsok, B.; Holsboer, F.; Keck, M. E.: Polymorphisms in the serotonin receptor gene HTR2A modulate disease severity and susceptibility for anxiety disorders but not depression and are associated with specific personality traits
A239
Vernaleken, I. B.; Kumakura, Y.; Buchholz, H. G.; Siessmeier, T.; Bartenstein, P.; Cumming, P.; Gründer, G.: Prefrontal cognitive performance of healthy subjects positively correlates with 18F-FDOPA uptake in positron emission tomography
A241
Walther, S.; Mahlberg, R.; Eichmann, U.; Kunz, D.: Treatment of night-time agitation in dementia with Δ-9-Tetrahydrocannabinol
A242
Weber, M.; Talmon, S.; Schulze, I.; Buschbacher, H.; Boeddinghaus, C.; Gross, G.; Wicke, K. M.: MAO-inhibitors and SSRIs inhibit running wheel activity without inhibiting motor activity
A244
Weber-Hamann, B.; Deuschle, M.; Lederbogen, F.; Kopf, D.; Bindeballe, N.; Gilles, M.; Heuser, I.: Metabolic syndrome in patients suffering from major depression
A245
Wehrle, R.; Kaufmann, C.; Wetter, T. C.; Holsboer, F.; Auer, D. P.; Pollmächer, T.; Czisch, M.: Functional neuroanatomical correlates of spectral EEG power during NREM sleep
A248
Welt, T.; Roedel, A.; Ohl, F.; Erhardt, A.; Keck, M. E.: The explorative-reduced (EXR002) C3H mice–a new mouse model of depression?
A250
Werner, C.; Spevakné-Göröcs, T.; Kungel, M.; Ebrecht, M.; Modell, S.: Individual symptom analysis in pivotal aripiprazole schizophrenia trials
A252
Wichniak, A.; Szafrañski, T.; Wierzbicka, A.; Musiñska, I.; Czasak, K.; Jernajczyk, W.: EEG response to brand-name and generic clozapine. Report of four cases
A254
Wiegand, M. H.; Landry, F.; Pohl, C.; Schlenker, I.; Brückner, T.; Veselý, Z.; Jahn, T.: Quetiapine in primary insomnia: a pilot study
A255
Wochnik, G. M.; Binder, E. B.; Salyakina, D.; Kohli, M. A.; Kloiber, S.; Holsboer, F.; Rein, T.: The Role of FKBP51 in the regulation of the glucocorticoid receptor
A256
Wurst, F. M.; Watson, B.; Haber, P. S.; Whitfield, J.; Wallace, C.; Lauer, J.; Weinmann, W.; Conigrave, K.: Alcohol consumption patterns amongst hepatitis C positive people receiving opioid maintenance treatment
A258
Zetzsche, T.; Frodl, T. S.; Schüle, C.; Baghai, T. C.; Seifert, D.; Tabrizi, S.; Preuss, U. W.; Schmitt, G.; Born, C.; Reiser, M.; Rupprecht, R.; Möller, H. J.; Meisenzahl, E.: Structural alterations of amygdala and hippocampus and HPA axis dysregulation in patients with borderline personality disorder
A260
Zimmermann, U.; Nakovics, H.; Smolka, M.; Mann, Ka; Project PREDICT study group,  : Validation of the inventory of drinking situations (IDS) to individualize alcoholism therapy
A261
Zobel, A.; Cardinal von Widdern, O.; Maier, W.: Pharmacogenetics of response to antidepressants
A262